Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription 09.12.2024 1 BMC Neurol 1 Diabet Med 2 Intern Med 1 J Pediatr Endocrinol Metab 2 J Rheumatol 6 Lancet 8 Mult Scler 2 Neurology 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. ALDEBASI T, Altuwaijri W, Gangadharan S, Alhammad D, et al
   Management and outcomes of pediatric optic neuritis in a tertiary hospital in Riyadh, Saudi Arabia: a retrospective study.
   BMC Neurol. 2024;24:474.
   PubMed         Abstract available
   
   

   
   Diabet Med

2. QUINN LM, Dias RP, Greenfield SM, Richter AG, et al
   Protocol for a feasibility and acceptability study for UK general population paediatric type 1 diabetes screening-the EarLy Surveillance for Autoimmune diabetes (ELSA) study.
   Diabet Med. 2024 Dec 2:e15490. doi: 10.1111/dme.15490.
   PubMed         Abstract available
   
   

   
   Intern Med

3. FUJII G, Yoshihara R, Hyodo T, Ishida I, et al
   An Autopsy Case of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Induced by Propylthiouracil.
   Intern Med. 2024;63:3197-3202.
   PubMed         Abstract available
   
   
4. SUMIKURA H, Ito M, Sato T, Hatayama N, et al
   Adult-onset Acute Flaccid Myelitis Accompanied by Rhombencephalitis Which First Presented with Prominent Psychiatric Symptoms and Dysautonomia Mimicking Anti-N-methyl-D-aspartate Receptor Encephalitis.
   Intern Med. 2024;63:3237-3241.
   PubMed         Abstract available
   
   

   
   J Pediatr Endocrinol Metab

5. FARHAT I, Drishti S, Bochner R, Bargman R, et al
   Do hybrid closed loop insulin pump systems improve glycemic control and reduce hospitalizations in poorly controlled type 1 diabetes?
   J Pediatr Endocrinol Metab. 2024;37:1028-1035.
   PubMed         Abstract available
   
   

   
   J Rheumatol

6. HASLAK F, Kilic H, Sahin S, Hotaman B, et al
   Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient Cohort.
   J Rheumatol. 2024;51:1208-1217.
   PubMed         Abstract available
   
   
7. MAILLE M, Tounkara BS, Vagner D, Bagny K, et al
   Epidemiology of isolated Cutaneous Lupus Erythematosus in the multiethnic population of Reunion Island (France): a retrospective multicentric study.
   J Rheumatol. 2024 Dec 1:jrheum.2024-0661. doi: 10.3899/jrheum.2024-0661.
   PubMed         Abstract available
   
   

   
   Lancet

8. HAGEN M, Muller F, Wirsching A, Kharboutli S, et al
   Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells.
   Lancet. 2024;404:2158-2160.
   PubMed        
   
   
9. PABST T, Maurer B
   Therapies for systemic lupus erythematosus.
   Lancet. 2024;404:2162.
   PubMed        
   
   
10. XU Q
    Therapies for systemic lupus erythematosus.
    Lancet. 2024;404:2162.
    PubMed        
    
    
11. HOI A, Igel T, Mok CC, Arnaud L, et al
    Therapies for systemic lupus erythematosus - Authors' reply.
    Lancet. 2024;404:2163-2164.
    PubMed        
    
    
12. MATUCHANSKY C
    Therapies for systemic lupus erythematosus.
    Lancet. 2024;404:2163.
    PubMed        
    
    
13. DE FREMONT GM, Lenfant T, Le Guern V, Costedoat-Chalumeau N, et al
    Therapies for systemic lupus erythematosus.
    Lancet. 2024;404:2163.
    PubMed        
    
    

    
    Mult Scler

14. LEFORT M, Dejardin O, Berger E, Camdessanche JP, et al
    Association between education level and disability progression in patients with multiple sclerosis in France.
    Mult Scler. 2024 Nov 30:13524585241289274. doi: 10.1177/13524585241289274.
    PubMed         Abstract available
    
    
15. LEFORT M, Dejardin O, Berger E, Camdessanche JP, et al
    Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France.
    Mult Scler. 2024 Dec 1:13524585241289276. doi: 10.1177/13524585241289276.
    PubMed         Abstract available
    
    
16. PORTACCIO E
    Toward a holistic approach to multiple sclerosis: The role of social determinants of health.
    Mult Scler. 2024 Dec 1:13524585241302684. doi: 10.1177/13524585241302684.
    PubMed        
    
    
17. CHITNIS T, Arnold DL, Quartier P, Chirieac M, et al
    Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study.
    Mult Scler. 2024 Dec 1:13524585241295554. doi: 10.1177/13524585241295554.
    PubMed         Abstract available
    
    
18. JIANG X, McGinley M, Johnston J, Alberts J, et al
    A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosis.
    Mult Scler. 2024 Dec 1:13524585241301854. doi: 10.1177/13524585241301854.
    PubMed         Abstract available
    
    
19. FRAMKE E, Sellebjerg F, Kant M, Stilund M, et al
    Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in Denmark.
    Mult Scler. 2024 Dec 4:13524585241299715. doi: 10.1177/13524585241299715.
    PubMed         Abstract available
    
    
20. KEVER A, Heuer LB, Simani L, Leavitt VM, et al
    Development and initial validation of the Cognitive Change Scale (CCS).
    Mult Scler. 2024;30:1815-1824.
    PubMed         Abstract available
    
    
21. CARVAJAL R, Rodriguez-Acevedo B, Garcia-Vasco L, Zabalza A, et al
    Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies.
    Mult Scler. 2024;30:1788-1801.
    PubMed         Abstract available
    
    

    
    Neurology

22. HARTUNG HP, Benedict RHB, Berger T, Bermel RA, et al
    Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.
    Neurology. 2024;103:e210049.
    PubMed         Abstract available
    
    
23. CRANE PD, Sillau S, Dreher R, Fix R, et al
    Population-Based Study of the Epidemiology of Stiff Person Syndrome in a Large Colorado-Based Health System.
    Neurology. 2024;103:e210078.
    PubMed         Abstract available
    
    

    
    PLoS One

24. MIRMOSAYYEB O, Yazdan Panah M, Mokary Y, Mohammadi M, et al
    Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0312421.
    PubMed         Abstract available
    
    
25. CHEIBCHALARD T, Leelahavanichkul A, Chatthanathon P, Klankeo P, et al
    Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
    PLoS One. 2024;19:e0314662.
    PubMed         Abstract available
    
    
26. TSUNODA R, Kume K, Kagawa R, Sanuki M, et al
    Machine-learning-based identification of patients with IgA nephropathy using a computerized medical billing database.
    PLoS One. 2024;19:e0312915.
    PubMed         Abstract available
    
    
27. RASOULI S, Dakkali MS, Ghazvini A, Azarbad R, et al
    Predictive model for converting optic neuritis to multiple sclerosis; decision tree in focus.
    PLoS One. 2024;19:e0309702.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.